Pancreatin and method for reducing the viral and microbial contamination of pancreatin
AssigneeNordmark Arzneimittel GmbH & Co. KG
InventorsManfred Kurfürst, Christian Rämsch, Thomas Schräder, Thomas Moest
Life of this patent
Estimating the term…
Loading patent…
AssigneeNordmark Arzneimittel GmbH & Co. KG
InventorsManfred Kurfürst, Christian Rämsch, Thomas Schräder, Thomas Moest
Estimating the term…
The invention relates to a method for producing pancreatin with reduced viral and microbial contamination, comprising the steps of (a) providing the pancreatin in solid form with a residual moisture of 0.5 weight % or less, down to almost zero, based on the pancreatin provided; (b) subjecting the pancreatin provided in step (a) to a heat treatment at a temperature of 84° C., preferably 80° C. and below; wherein, the biological activity of the pancreatin obtained in step (b) corresponds to at least 50% of the biological activity of the pancreatin provided in step (a); and the viral infectiousness of the pancreatin obtained in step (b) has been reduced by a factor of more than 1 log10 in comparison with the viral infectiousness of the pancreatin provided in step (a), as well as a pancreatin produced according to this method and its use for producing a medicine or a nutritional supplement.
A pancreatin product of reduced microbial and viral contamination produced by a method comprising the steps of:
A method for producing pancreatin with reduced viral and microbial contamination, comprising the steps of:
A pancreatin product produced by the following steps:
A pancreatin product with reduced microbial and viral contamination produced by the following steps:
A pancreatin product with reduced microbial and viral contamination produced by the following steps:
Dependencies are inferred from the claim text.